An Open-label Phase 4 Study to Evaluate the Immunogenicity and Safety of Intramuscular Injections of BLB-750 in Healthy Adult Subjects
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 16 Jan 2018
At a glance
- Drugs Influenza A virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Takeda
- 16 Jan 2018 Planned End Date changed from 25 Feb 2018 to 31 Mar 2018.
- 16 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 22 Dec 2017 Planned End Date changed from 31 Mar 2018 to 25 Feb 2018.